Seattle, WA
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxi... Read more
altpep.comThese are collections AltPep is a part of. Click on the collection name to view similar companies.
Series B
$52,900,000
Series A
$23,150,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AltPep.